Dynamic changes of urinary proteins in a focal segmental glomerulosclerosis rat model

Proteome Science

Volumn 12, Issue 1, 2014, Pages

  Zhao, Mindi ^a   Li, Menglin ^a   Li, Xundou ^a   Shao, Chen ^a   Yin, Jianrui ^a   Gao, Youhe ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Animal model; Biomarker; Focal segmental glomerulosclerosis; Urine proteome

Indexed keywords

BETA 2 MICROGLOBULIN;

ADRIAMYCIN-INDUCED NEPHROPATHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE SEVERITY; FOCAL GLOMERULOSCLEROSIS; HUMAN; HUMAN FOCAL SEGMENTAL GLOMERULOSCLEROSIS; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; RAT; RAT MODEL; TANDEM MASS SPECTROMETRY; URINALYSIS; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 84904445971     PISSN: None     EISSN: 14775956     Source Type: Journal    
DOI: 10.1186/1477-5956-12-42     Document Type: Article

References (41)

1. Gao Y. Urine-an untapped goldmine for biomarker discovery?. Sci China Life Sci 2013, 56:1145-1146.
2. Li M, Zhao M, Gao Y. Changes of proteins induced by anticoagulants can be more sensitively detected in urine than in plasma. Sci China Life Sci 2014, 57:649-656.
3. Decramer S, de Gonzalez Peredo A, Breuil B, Mischak H, Monsarrat B, Bascands JL, Schanstra JP. Urine in clinical proteomics. Mol Cell Proteomics 2008, 7:1850-1862.
4. Kitiyakara C, Kopp JB, Eggers P. Trends in the epidemiology of focal segmental glomerulosclerosis. Semin Nephrol 2003, 23:172-182.
5. Kiffel J, Rahimzada Y, Trachtman H. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis 2011, 18:332-338.
6. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med 2011, 365:2398-2411.
7. Thomas DB. Focal segmental glomerulosclerosis: a morphologic diagnosis in evolution. Arch Pathol Lab Med 2009, 133:217-223.
8. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol 2009, 296:F213-F229.
9. Lee VW, Harris DC. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis. Nephrology (Carlton) 2011, 16:30-38.
10. Wang L, Li F, Sun W, Wu S, Wang X, Zhang L, Zheng D, Wang J, Gao Y. Concanavalin A-captured glycoproteins in healthy human urine. Mol Cell Proteomics 2006, 5:560-562.
11. Uen YH, Lin KY, Sun DP, Liao CC, Hsieh MS, Huang YK, Chen YW, Huang PH, Chen WJ, Tai CC, Lee KW, Chen YC, Lin CY. Comparative proteomics, network analysis and post-translational modification identification reveal differential profiles of plasma Con A-bound glycoprotein biomarkers in gastric cancer. J Proteomics 2013, 83:197-213.
12. Shaye DD, Greenwald I. OrthoList: a compendium of C. elegans genes with human orthologs. PLoS One 2011, 6:e20085.
13. Jia L, Li X, Shao C, Wei L, Li M, Guo Z, Liu Z, Gao Y. Using an isolated rat kidney model to identify kidney origin proteins in urine. PLoS One 2013, 8:e66911.
14. Shao C, Wang Y, Gao Y. Applications of urinary proteomics in biomarker discovery. Sci China Life Sci 2011, 54:409-417.
15. Jia L, Zhang L, Shao C, Song E, Sun W, Li M, Gao Y. An attempt to understand kidney's protein handling function by comparing plasma and urine proteomes. PLoS One 2009, 4:e5146.
16. Saha S, Harrison SH, Shen C, Tang H, Radivojac P, Arnold RJ, Zhang X, Chen JY. HIP2: an online database of human plasma proteins from healthy individuals. BMC Med Genom 2008, 1:12.
17. Marimuthu A, O'Meally RN, Chaerkady R, Subbannayya Y, Nanjappa V, Kumar P, Kelkar DS, Pinto SM, Sharma R, Renuse S, Goel R, Christopher R, Delanghe B, Cole RN, Harsha HC, Pandey A. A comprehensive map of the human urinary proteome. J Proteome Res 2011, 10:2734-2743.
18. Li QR, Fan KX, Li RX, Dai J, Wu CC, Zhao SL, Wu JR, Shieh CH, Zeng R. A comprehensive and non-prefractionation on the protein level approach for the human urinary proteome: touching phosphorylation in urine. Rapid Commun Mass Spectrom 2010, 24:823-832.
19. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol 2006, 7:R80.
20. Sun W, Chen Y, Li F, Zhang L, Yang R, Zhang Z, Zheng D, Gao Y. Dynamic urinary proteomic analysis reveals stable proteins to be potential biomarkers. Proteomics Clin Appl 2009, 3:370-382.
21. Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome. J Proteome Res 2011, 10:637-645.
22. Lopez-Hellin J, Cantarell C, Jimeno L, Sanchez-Fructuoso A, Puig-Gay N, Guirado L, Vilarino N, Gonzalez-Roncero FM, Mazuecos A, Lauzurica R, Burgos D, Plumed JS, Jacobs-Cacha C, Jimenez C, Fernandez A, Fernandez-Alvarez P, Torregrosa V, Nieto JL, Meseguer A, Alonso A, Group GS. A form of apolipoprotein a-I is found specifically in relapses of focal segmental glomerulosclerosis following transplantation. Am J Transplant 2013, 13:493-500.
23. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G, Dakshinamurthy KV, Roberts CT, Nagalla SR. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007, 30:629-637.
24. Shui HA, Huang TH, Ka SM, Chen PH, Lin YF, Chen A. Urinary proteome and potential biomarkers associated with serial pathogenesis steps of focal segmental glomerulosclerosis. Nephrol Dial Transplant 2008, 23:176-185.
25. Narita T, Sasaki H, Hosoba M, Miura T, Yoshioka N, Morii T, Shimotomai T, Koshimura J, Fujita H, Kakei M, Ito S. Parallel increase in urinary excretion rates of immunoglobulin G, ceruloplasmin, transferrin, and orosomucoid in normoalbuminuric type 2 diabetic patients. Diabetes Care 2004, 27:1176-1181.
26. Wu DL, Zhang WH, Wang WJ, Jing SB, Xu YM. Proteomic evaluation of urine from renal cell carcinoma using SELDI-TOF-MS and tree analysis pattern. Technol Cancer Res Treat 2008, 7:155-160.
27. Wai-Hoe L, Wing-Seng L, Ismail Z, Lay-Harn G. Proteomics and detection of uromodulin in first-time renal calculi patients and recurrent renal calculi patients. Appl Biochem Biotechnol 2009, 159:221-232.
28. Kentsis A, Lin YY, Kurek K, Calicchio M, Wang YY, Monigatti F, Campagne F, Lee R, Horwitz B, Steen H, Bachur R. Discovery and validation of urine markers of acute pediatric appendicitis using high-accuracy mass spectrometry. Ann Emerg Med 2010, 55:62-70. e64.
29. Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol 2005, 16:1126-1134.
30. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 2007, 18:904-912.
31. Mesrobian HG, Mitchell ME, See WA, Halligan BD, Carlson BE, Greene AS, Wakim BT. Candidate urinary biomarker discovery in ureteropelvic junction obstruction: a proteomic approach. J Urol 2010, 184:709-714.
32. Cutillas PR, Chalkley RJ, Hansen KC, Cramer R, Norden AG, Waterfield MD, Burlingame AL, Unwin RJ. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004, 287:F353-F364.
33. Mirkovic K, Doorenbos CR, Dam WA, Lambers Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van den Born J, Navis G, de Borst MH. Urinary vitamin D binding protein: a potential novel marker of renal interstitial inflammation and fibrosis. PLoS One 2013, 8:e55887.
34. Shao C, Li M, Li X, Wei L, Zhu L, Yang F, Jia L, Mu Y, Wang J, Guo Z, Zhang D, Yin J, Wang Z, Sun W, Zhang Z, Gao Y. A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol Cell Proteomics 2011, 10:M111 010975.
35. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit?. Kidney Int 1998, 54:687-697.
36. Vilasi A, Cutillas PR, Maher AD, Zirah SF, Capasso G, Norden AW, Holmes E, Nicholson JK, Unwin RJ. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 2007, 293:F456-F467.
37. Gao Y. Roadmap to the Urine Biomarker Era. MOJ Proteomics Bioinform 2014, 1:00005.
38. Price CP, Newall RG, Boyd JC. Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review. Clin Chem 2005, 51:1577-1586.
39. Wang Y, Chen Y, Zhang Y, Wu S, Ma S, Hu S, Zhang L, Shao C, Li M, Gao Y. Differential ConA-enriched urinary proteome in rat experimental glomerular diseases. Biochem Biophys Res Commun 2008, 371:385-390.
40. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Methods 2009, 6:359-362.
41. Hauck SM, Dietter J, Kramer RL, Hofmaier F, Zipplies JK, Amann B, Feuchtinger A, Deeg CA, Ueffing M. Deciphering membrane-associated molecular processes in target tissue of autoimmune uveitis by label-free quantitative mass spectrometry. Mol Cell Proteomics 2010, 9:2292-2305.